ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1290

$955K Total Retail Price of All Prescriptions

Rank: 56 out of 1290

523 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 523 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 523 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,679 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 399 333 1 4
OMEPRAZOLE 342 319 2 2
SIMVASTATIN 306 237 3 1
AMLODIPINE BESYLATE 297 233 4 3
HYDROCODONE-ACETAMINOPHEN 258 242 S3 5 6
FUROSEMIDE 255 243 6 9
METOPROLOL TARTRATE 223 194 7 7
LISINOPRIL 200 163 8 5
LOSARTAN POTASSIUM 195 183 9 19
PRAVASTATIN SODIUM 187 182 10 42
CRESTOR 156 131 11 17
ATENOLOL 152 142 12 18
CITALOPRAM HBR 150 141 13 29
DIOVAN HCT 140 126 14 112
DONEPEZIL HCL 139 139 15 13
NEXIUM 139 103 15 34
LOVAZA 131 118 17 131
GLIMEPIRIDE 119 118 18 57
PANTOPRAZOLE SODIUM 119 105 18 48
POTASSIUM CHLORIDE 119 107 18 35
WARFARIN SODIUM 119 117 18 22
METOPROLOL SUCCINATE 116 110 22 14
ALENDRONATE SODIUM 115 96 23 39
ZOLPIDEM TARTRATE 110 87 24 15
GLYBURIDE 107 103 R 25 87
SERTRALINE HCL 100 88 26 36
HYDROCHLOROTHIAZIDE 97 86 27 20
CARVEDILOL 94 77 28 12
TRAMADOL HCL 91 71 29 25
ISOSORBIDE MONONITRATE ER 88 83 30 58
AZITHROMYCIN 87 64 31 61
CLOPIDOGREL 86 63 32 24
CLONIDINE HCL 85 66 33 66
METFORMIN HCL 83 77 34 10
ATORVASTATIN CALCIUM 82 61 35 23
GABAPENTIN 79 63 36 8
PREDNISONE 79 68 36 21
ESCITALOPRAM OXALATE 79 74 36 63
SYNTHROID 78 46 39 28
LOSARTAN-HYDROCHLOROTHIAZIDE 78 75 39 106
LEVOFLOXACIN 73 62 41 150
PROAIR HFA 71 37 42 73
BENICAR 67 63 43 205
FAMOTIDINE 66 56 44 128
DIGOXIN 64 55 45 51
DIOVAN 62 57 46 53
LOVASTATIN 59 49 47 45
SINGULAIR 58 43 48 85
GLIPIZIDE 58 58 48 81
NIFEDIPINE ER 57 57 50 110
LYRICA 54 39 51 94
PLAVIX 54 40 51 32
ACTOS 52 45 53 182
RAMIPRIL 52 48 53 136
ENALAPRIL MALEATE 51 35 55 62
NAMENDA 50 50 56 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.